Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr206.10 SEK
Change Today -0.80 / -0.39%
Volume 612.9K
GETIB On Other Exchanges
Symbol
Exchange
Stockholm
Berlin
OTC US
OTC US
As of 11:30 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

getinge ab-b shs (GETIB) Snapshot

Open
kr206.90
Previous Close
kr206.90
Day High
kr208.00
Day Low
kr205.50
52 Week High
04/16/15 - kr236.20
52 Week Low
10/16/14 - kr147.00
Market Cap
49.1B
Average Volume 10 Days
599.7K
EPS TTM
kr7.74
Shares Outstanding
222.4M
EX-Date
03/26/15
P/E TM
26.6x
Dividend
kr2.80
Dividend Yield
1.36%
Current Stock Chart for GETINGE AB-B SHS (GETIB)

Related News

No related news articles were found.

getinge ab-b shs (GETIB) Related Businessweek News

No Related Businessweek News Found

getinge ab-b shs (GETIB) Details

Getinge AB provides products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care, and for life science companies and institutions. The company’s Medical Systems business area offers products for cardiac surgery and intensive care, and surgical workstation systems under the Maquet brand. This business area’s product portfolio comprises surgical tables, surgical lights, ceiling supply units, clinical logistics, OR integration, and modular operating rooms; perfusion products; products for cardio and vascular surgery, heart support, and interventional cardiology; and mobile ventilation solutions, portable heart-lung products, and radiology-adapted transfer solutions, as well as anesthesia systems and other monitoring products. The company’s Extended Care business area provides caregiver equipment for patients with reduced mobility under the ArjoHuntleigh brand. It offers patient handling products, including products for lifting, transferring, and showering and bathing systems; products for the prevention and treatment of pressure ulcers; hospital beds, stretchers, and couches; and diagnostic products, such as dopplers and products for fetal monitoring. The company’s Infection Control business area offers washer and flusher disinfectors, sterilization equipment, and IT-systems and loading equipment under the Getinge brand. It operates in Western Europe, the United States, Canada, and internationally. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.

15,747 Employees
Last Reported Date: 03/2/15
Founded in 1904

getinge ab-b shs (GETIB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

getinge ab-b shs (GETIB) Key Developments

Getinge Group Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 2015

Getinge Group reported consolidated earnings results for the first quarter ended March 2015. For the period, the company reported net sales of SEK 6,712 million against SEK 5,632 million a year ago. Operating profit was SEK 335 million against operating loss of SEK 294 million a year ago. Profit before tax was SEK 146 million against loss before tax of SEK 452 million a year ago. Net profit attributable to parent company's shareholders was SEK 90 million or SEK 0.38 per share against net loss attributable to parent company's shareholders of SEK 331 million or SEK 1.39 per share a year ago. Adjusted Earnings per share was SEK 1.62 against SEK 1.57 million a year ago. Cash flow from operations was SEK 654 million against SEK 438 million a year ago. Capitalized development costs were SEK 154 million against SEK 157 million a year ago. Investments in tangible fixed assets was SEK 188 million against SEK 172 million a year ago. EBITA before restructuring costs increased by 7.0% to SEK 717 million against SEK 670 million a year ago. EBITA before restructuring, positively impacted by the non-recurring effect of approximately SEK 76 million from the divestment of Pulsion's perfusion business to Diagnostic Green GmbH. The financial consequences of the Consent Decree with the FDA had a negative impact on EBITA of approximately SEK 50 million for loss of revenue and higher costs. Net interest-bearing debt was SEK 23,526,000 against SEK 20,171,000 for the same period a year ago. Return on equity was 14.9% against 11.2% for the same period a year ago.

Getinge AB, Q1 2015 Earnings Call, Apr 20, 2015

Getinge AB, Q1 2015 Earnings Call, Apr 20, 2015

Getinge AB Elects Alex Myers as Member of the Board; Approves Dividend

Getinge AB announced that at the Annual General Meeting held on 25 March 2015 Alex Myers was elected as new member of the Board. The company also announced that Annual General Meeting resolved to declare a dividend of SEK 2.80 per share. 27 March 2015 was determined as record date for dividend.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GETIB:SS kr206.10 SEK -0.80

GETIB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $51.58 USD +0.22
DENTSPLY International Inc $52.04 USD -0.115
MEDNAX Inc $71.18 USD +0.32
PerkinElmer Inc $52.73 USD -0.36
Teleflex Inc $128.74 USD -0.06
View Industry Companies
 

Industry Analysis

GETIB

Industry Average

Valuation GETIB Industry Range
Price/Earnings 27.1x
Price/Sales 1.8x
Price/Book 2.8x
Price/Cash Flow 25.3x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GETINGE AB-B SHS, please visit www.getingegroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.